Primary |
Induction Of Anaesthesia |
26.5% |
Anaesthesia |
17.6% |
Analgesic Therapy |
14.7% |
General Anaesthesia |
14.7% |
Musculoskeletal Pain |
8.8% |
Product Used For Unknown Indication |
5.9% |
Antibiotic Prophylaxis |
2.9% |
Attention Deficit/hyperactivity Disorder |
2.9% |
Maintenance Of Anaesthesia |
2.9% |
Retinal Detachment |
2.9% |
|
Drug Interaction |
14.3% |
Dystonia |
14.3% |
Myotonia |
14.3% |
Procedural Complication |
14.3% |
Product Quality Issue |
14.3% |
Treatment Failure |
14.3% |
Urticaria |
14.3% |
|
Secondary |
Drug Use For Unknown Indication |
25.1% |
Product Used For Unknown Indication |
14.0% |
Anaesthesia |
12.8% |
General Anaesthesia |
9.7% |
Induction Of Anaesthesia |
5.6% |
Pneumonia |
4.9% |
Analgesia |
3.7% |
Analgesic Therapy |
3.7% |
Drug Abuse |
2.2% |
Pain |
2.2% |
Varicose Vein Operation |
2.2% |
Musculoskeletal Pain |
2.0% |
Prophylaxis |
2.0% |
Antiphospholipid Syndrome |
1.7% |
Maintenance Of Anaesthesia |
1.7% |
In Vitro Fertilisation |
1.6% |
Anaesthesia Procedure |
1.3% |
Sensory Disturbance |
1.3% |
Renal Transplant |
1.2% |
Vitamin Supplementation |
1.2% |
|
Toxic Epidermal Necrolysis |
20.0% |
Anaphylactic Shock |
10.0% |
Toxicity To Various Agents |
7.8% |
Cardiac Arrest |
6.7% |
Myotonia |
6.7% |
Sinus Tachycardia |
6.7% |
Therapeutic Agent Toxicity |
6.7% |
Hypotension |
5.6% |
Sedation |
5.6% |
Premature Rupture Of Membranes |
3.3% |
Maternal Exposure During Pregnancy |
2.2% |
Myoclonus |
2.2% |
Procedural Hypotension |
2.2% |
Resuscitation |
2.2% |
Somnolence |
2.2% |
Tachycardia |
2.2% |
Transaminases Increased |
2.2% |
Upper Airway Obstruction |
2.2% |
Varicose Vein Operation |
2.2% |
Anaphylactic Reaction |
1.1% |
|
Concomitant |
Product Used For Unknown Indication |
22.6% |
Anaesthesia |
19.5% |
Drug Use For Unknown Indication |
11.0% |
Pain |
6.3% |
Analgesia |
6.0% |
Crohn's Disease |
4.7% |
Premedication |
4.7% |
Sedation |
4.0% |
Induction Of Anaesthesia |
3.6% |
General Anaesthesia |
3.1% |
Prophylaxis |
2.7% |
Cancer Pain |
1.8% |
Prostate Cancer |
1.5% |
Staphylococcal Infection |
1.5% |
Convulsion |
1.2% |
Drug Abuse |
1.2% |
Drug Withdrawal Syndrome |
1.2% |
Preoperative Care |
1.2% |
Analgesic Therapy |
1.1% |
Antibiotic Prophylaxis |
1.1% |
|
Therapeutic Agent Toxicity |
15.0% |
Staring |
10.0% |
Rhabdomyolysis |
8.3% |
Tubulointerstitial Nephritis |
7.5% |
Scleroderma |
5.0% |
Vomiting |
5.0% |
White Blood Cell Count Increased |
5.0% |
Liver Function Test Abnormal |
4.2% |
Pancreatitis |
4.2% |
Tachycardia |
4.2% |
Toxic Epidermal Necrolysis |
4.2% |
Ectopic Pregnancy |
3.3% |
Multi-organ Failure |
3.3% |
Pulmonary Embolism |
3.3% |
Pupil Fixed |
3.3% |
Somnolence |
3.3% |
Ventricular Tachycardia |
3.3% |
Agitation |
2.5% |
Blister |
2.5% |
Disease Progression |
2.5% |
|
Interacting |
General Anaesthesia |
40.7% |
Osteotomy |
16.8% |
Musculoskeletal Pain |
8.1% |
Drug Use For Unknown Indication |
7.9% |
Neuralgia |
7.1% |
Pain |
5.2% |
Maintenance Of Anaesthesia |
3.7% |
Anaesthesia |
3.5% |
Varicose Vein Operation |
3.1% |
Induction Of Anaesthesia |
2.9% |
Encephalopathy |
0.6% |
Attention Deficit/hyperactivity Disorder |
0.2% |
|
Sinus Tachycardia |
51.2% |
Myotonia |
34.9% |
No Adverse Event |
7.0% |
Drug Interaction |
4.7% |
Myoclonus |
2.3% |
|